No recent analyst price targets found for SFUNY.
Latest News for SFUNY
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
MALVERN, Pa., July 01, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced the promotion of Cheng Fang, Ph.D., to Chief Scientific Officer.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SFUNY.
U.S. House Trading
No House trades found for SFUNY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.